MICHELE ANTONIO MARIA VIGNALI

Prof. Dr. MICHELE ANTONIO MARIA VIGNALI

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
MBMauro Busacca
Mauro Busacca
JRJennifer Riparini
Jennifer Riparini
ESEdgardo Somigliana
Edgardo Somigliana
GOGiulia Oggioni
Giulia Oggioni
SIStefano Izzo
Stefano Izzo
MCMassimo Candiani
Massimo Candiani

22 March 2006 in Journal of Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
PVP Viganò
P Viganò
DLD Lattuada
D Lattuada
SMS Mangioni
S Mangioni
LEL Ermellino
L Ermellino
MVMICHELE ANTONIO MARIA VIGNALI
MICHELE ANTONIO MARIA VIGNALI
ABAnna Maria Di Blasio
Anna Maria Di Blasio
In addition to its calciotropic function, the secosteroid 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), has potent anti-proliferative/immunomodulatory effects on various tissues. Consistently, the enzyme that catalyzes the synthesis of 1,25(OH)2D3, 1α-hydroxylase (1α-OHase) and the vitamin D receptor have a widespread tissue distribution. Among site-specific functions, the hormone has been suggested to be involved in uterine physiology. However, molecular analysis of the vitamin D system in normal endometrium throughout the menstrual cycle as well as its regulation in the context of endometrial physiological and pathological events have received very limited attention. Thus, we have studied expression, localization and regulation of 1α-OHase in human cycling and early pregnant endometrium. The capacity for 1α-hydroxylation and the presence of vitamin D receptor in endometrial cells have also been evaluated. The functional significance of these findings has been tested by evaluating gene expression of the catabolic enzyme, vitamin D 24-hydroxylase, and of the adhesion protein, osteopontin. Finally, to verify any potential dysfunction of the vitamin D system in endometriosis, a reproductive disease characterized by immune-mediated anomalies, we have analyzed expression of 1α-OHase in both eutopic and ectopic endometrium of affected patients. Results obtained showed that the active form of the 1α-OHase gene was expressed in human endometrial stromal cells independent of the cycle phase but with a significant increase in early pregnant decidua. A similar profile was observed for the protein, which was abundantly expressed in the cytoplasm of both endometrial stroma and epithelial glands. Both cycling and early pregnant endometrial cells also expressed the vitamin D receptor. In the same cells, 1α-OHase mRNA levels were significantly stimulated by the pro-inflammatory cytokine interleukin (IL)-1β (50 and 500 pg/ml) while addition of the active form of the hormone could modulate both CYP24 and osteopontin gene expression. The 1α-OHase gene was also expressed in ectopic endometrium and its levels were increased in proliferative phase cultures derived from patients with endometriosis. Human cycling endometrium may be included among the extrarenal sites able to synthesize vitamin D. The IL-1β-mediated induction of 1α-OHase gene and the hormonal modulation of osteopontin support a role for the hormone in the immunological mechanisms underlying uterine function. Abnormalities of this system are present in endometriosis.

1 December 2005 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
MVMICHELE ANTONIO MARIA VIGNALI
MICHELE ANTONIO MARIA VIGNALI
BSBianchi Stefano
Bianchi Stefano
MCMassimo Candiani
Massimo Candiani
GSGiovanna Spadaccini
Giovanna Spadaccini
GOGiulia Oggioni
Giulia Oggioni
MBMauro Busacca
Mauro Busacca

9 March 2007 in Molecular Human Reproduction
Verified
Journal Article
Open access
PDF file
gentilini davidegentilini davide
gentilini davide
MBM. Busacca
M. Busacca
SFS. Di Francesco
S. Di Francesco
MVMICHELE ANTONIO MARIA VIGNALI
MICHELE ANTONIO MARIA VIGNALI
Paola Vigano'Paola Vigano'
Paola Vigano'
ABAnna Maria Di Blasio
Anna Maria Di Blasio
Cell motility and invasion are crucial events for endometrial cells, not only for the establishment of pathological states but also during the physiological tissue remodelling that occurs during the menstrual cycle and embryo implantation. We have characterized these phenomena in endometrial stromal cells evaluating cell migration-specific stimuli and the biochemical pathways involved. Ability of endometrial cells to migrate on collagen type IV substrate was evaluated by means of chemotaxis experiments. Modulation of this phenomenon by different growth factors and steroid hormones and their ability to activate extracellular signal-regulated protein kinase (ERK) and phosphatidylinositol 3 kinase (PI3K)/Akt signalling in this context were examined. Platelet-derived growth factor (PDGF)-BB, epidermal growth factor and fibroblast growth factor-2 as chemoattractant agents stimulated basal migration of endometrial stromal cells through the rapid activation of both ERK1/2 and PI3K/Akt signalling pathways. Experiments using wortmannin and PD98059, specific inhibitors of the PI3K/Akt and ERK1/2 activity, respectively, showed that the activation of both pathways is required for growth-factor-induced cell motility responses. Similarly, 17β-estradiol (10−6–10−8 M) could enhance both constitutive and PDGF-induced migration of the cells and their rapid treatment with the hormone significantly increased phosphorylation of ERK1/2 and Akt. Conversely, progesterone did not interfere with the basal migration but inhibits the PDGF-induced motility of this cell type. Rapid activation of intracellular signalling cascades ERK1/2 and PI3K/Akt by growth factors and estrogens is involved in the migration of normal endometrial stromal cells.

1 August 2006 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
MBMauro Busacca
Mauro Busacca
FCFrancesca Chiaffarino
Francesca Chiaffarino
MCMassimo Candiani
Massimo Candiani
MVMICHELE ANTONIO MARIA VIGNALI
MICHELE ANTONIO MARIA VIGNALI
CBCarlo Bertulessi
Carlo Bertulessi
Fabio ParazziniFabio Parazzini
Fabio Parazzini

1 August 2004 in Gynecologic Oncology
Verified
Journal Article
Closed access
AMAndrea Maneo
Andrea Maneo
MVMICHELE ANTONIO MARIA VIGNALI
MICHELE ANTONIO MARIA VIGNALI
SCStefania Chiari
Stefania Chiari
ACAndrea Colombo
Andrea Colombo
CMCostantino Mangioni
Costantino Mangioni
FLFabio Landoni
Fabio Landoni